JAZZ
Jazz Pharmaceuticals PLC
234.90$
-2.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 20.0% | 15.5% | 13.6% | 20.6% | 7.5% | 7.8% | 5.1% | 13.4% | 11.7% | 10.0% | 7.7% | 7.1% | 6.8% | 6.4% | 5.9% | 6.3% | 14.2% | 14.8% | 11.4% | 11.0% | 11.8% | |
| – | 80.0% | 84.5% | 86.4% | 79.4% | 92.5% | 92.2% | 94.9% | 86.6% | 88.3% | 90.0% | 92.3% | 92.9% | 93.2% | 93.6% | 94.1% | 93.7% | 85.8% | 85.2% | 88.6% | 89.0% | 88.2% | |
| – | 213.5% | 122.5% | 106.9% | 103.6% | 28.5% | 14.7% | 5.2% | 3.5% | 5.3% | 7.3% | 10.2% | 10.9% | 12.3% | 12.0% | 13.9% | 14.2% | 16.3% | 16.1% | 22.2% | 21.7% | 18.3% | |
| – | 323.4% | 237.1% | 120.2% | 165.0% | 45.7% | 39.7% | 40.0% | 38.1% | 34.8% | 32.4% | 33.8% | 33.7% | 33.6% | 36.1% | 34.1% | 36.1% | 46.9% | 38.7% | 34.7% | 34.0% | 42.4% | |
| – | 445.8% | 258.5% | 298.9% | 331.7% | 80.1% | 58.9% | 47.9% | 52.9% | 49.3% | 73.3% | 53.9% | 53.2% | 60.5% | 61.1% | 69.5% | 77.7% | 80.3% | 87.0% | 73.5% | 71.4% | 82.9% | |
| – | -365.8% | -174.0% | -212.5% | -252.3% | 12.4% | 33.3% | 46.9% | 33.8% | 39.0% | 16.7% | 38.4% | 39.8% | 32.7% | 32.5% | 24.6% | 16.0% | 5.5% | -1.8% | 15.1% | 17.6% | 5.3% | |
| – | 0.0% | 0.0% | 20.9% | 29.2% | 17.7% | 7.3% | 0.6% | 2.9% | 3.1% | 4.5% | 4.3% | 4.2% | 4.8% | 4.2% | 3.3% | 4.2% | 9.0% | 7.9% | 7.5% | 5.9% | 4.6% | |
| – | -397.1% | -132.4% | -212.6% | -273.0% | -5.3% | 18.9% | 45.9% | 30.3% | 35.3% | 12.9% | 32.9% | 35.8% | 27.2% | 27.9% | 20.8% | 11.5% | -3.7% | -10.5% | 7.7% | 11.5% | -14.7% | |
| – | 130.6% | -41.6% | 0.1% | 64.8% | 17.7% | 14.4% | 1.0% | -14.3% | 10.5% | 8.0% | 8.0% | 9.1% | -2.9% | 4.2% | -3.4% | 1.4% | 7.0% | -4.3% | -3.1% | -2.2% | -6.4% | |
| – | -397.1% | -132.4% | -212.6% | -273.0% | -5.3% | 18.9% | 45.9% | 49.2% | 24.8% | 5.0% | 24.9% | 26.7% | 30.1% | 23.6% | 24.2% | 10.1% | -10.6% | -6.1% | 10.8% | 13.8% | -8.3% | |
| – | -241.1% | -151.0% | -196.4% | -186.0% | 19.5% | 31.2% | 49.4% | 52.9% | 52.1% | 49.8% | 50.3% | 50.7% | 48.1% | 49.3% | 46.8% | 44.2% | 33.2% | 40.1% | 37.8% | 37.4% | 2.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.